Abstract
9599 Background: Accurate assessment of toxicity allows for timely delivery of necessary supportive measures during radiotherapy (RT) treatment for head and neck cancer. The purpose of this prospective trial is to evaluate the feasibility of using mobile device technology to collect daily patient reported symptoms. Methods: A HIPAA-secure mobile application was developed to allow patients receiving RT for head and neck cancer to report symptom severity in five domains (fatigue, pain, nausea/vomiting, decreased appetite, anxiety) using the Patient Reported Symptom Monitoring System questionnaire. Patients were asked to report symptoms using a smartphone and/or tablet at least once daily during treatment or more often as needed. Patient surveys regarding use of mobile devices were obtained after completion of RT. Descriptive statistics, linear regression, and Fisher's exact test were used to examine factors associated with symptom reporting. Results: 22 patients enrolled and 1 withdrew consent. A total of 9...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
